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Abstract 
 The number of citations of a scientific article is considered as the  weight of that work in 
the field of interest. Bibliometric/Scientometric analysis of the most cited articles conducted in 
some medical disciplines has identified the most relevant scientific contributions that pushed 
forward knowledge and practice of that discipline. We conducted a bibliometrics/Scientometric 
analysis of the most cited articles in Covid-19 Drugs, Vaccines and Medicines, by extracting 
relevant words that identify and querying the Scopus online database. A rank with the 100, 500 
and 1000 above Citations of the most cited articles was obtained, based on the absolute number 
of citations. Word(s) extracted from the Scopus database. Among the Highly cited articles there 
are 22 articles received more than 1000 Citations, 83 articles have  recorded  more than 500 
Citations and 816 articles recorded 100 Citations. A total of 22005 scientific journals had 
published the top 816 most cited articles in Covid-19 Drugs, Medicine and Vaccines of 
publications are published in reputed journals like The Lancet, Cell, Cell Research, New 
England Journal of Medicine, International Journal of Antimicrobial Agents, The Lancet 
Infectious Diseases, Allergy: Eropeans Journal of Allergy and Clinical Immunology, Military 
Medical Research, BioScience Trends, Journal of Hospital Infection, The Lancel Respiratory 
Medicine etc.. 
 




 Citation Classics will enable the authors of these papers to discuss their work 
retrospectively. It is the kind of science ‘reviewing’ rarely seen in scientific journals. It will 
provide a kind of living history. Authors will discuss interesting aspects in the development of 
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their techniques, the role played by coauthors or others, and the encouragement received from 
colleagues. This is the human side of science. 
 In recent years, efforts have been made to define relevant articles in Covid-19 specialty 
areas (Drugs, Medicines and Vaccines) by identifying the  most cited articles. We therefore 
employed a bibliometrics analysis aimed at identifying the top 100 most cited scientific articles 
on Covid-19 Vaccines, Drugs and medicines. 
 
Short History of Citation Classics Commentaries by Eugene Garfield 
 From 1977 to 1993, four thousand Citation Classic Commentaries were published in 
Current Contents.  The full texts of these mostly one-page articles are now available in an open 
access server at: http://garfield.library.upenn.edu/classics.html 
 
 On January 3, 1977 essay -" Introducing Citation Classics:  The human side of scientific 
papers “appeared in Current Contents.  The first group was selected from the 500 papers most-
cited from 1961-1975. This collection contained some of the most-cited papers ever published.   
 First  Citation Classics  commentary  by Oliver H. Lowry was a fitting choice as his 1951 
paper  is   the most-cited paper in the history of science.1   Over the past eleven  years since this 
feature of  Current Contents was concluded,  numerous  readers have requested  copies of these 
commentaries.  The reason is quite simple : most libraries do not store the print version of 
Current Contents.  
 
What is a Citation Classic? 
 A Citation Classic is a highly cited publication as identified by the Science Citation Index 
(SCI) the Social Sciences Citation Index (SSCI), or the Arts & Humanities Citation Index 
(A&HCI). Citation rates differ for each discipline.  The number of citations indicating a classic 
in botany, a small field, might be lower than the number required to make a classic in a large 
field like biochemistry.  In general, a publication cited more than 400 times should be considered 
a classic; but in some fields with fewer researchers, 100 citations might qualify a work.   
 Citation Classics authors were asked to write an abstract and a commentary about the 
publication, emphasizing the human side of the research - how the project was initiated, whether 
any obstacles were encountered, and why the work was highly cited. Undoubtedly most of these 
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authors will not only be among the most cited, but also the most highly-qualified in their 
respective fields. The candidates for Citation Classics will be selected from a group of 500 
papers most cited during the years 1961-1975. Many of these have been listed before in Current 
Contents. 
 
OBJECTIVES OF THE STUDY 
 The following are the major objectives of this study 
• To identify most cited Sources.  
• To identify the most cited Countries;  
• To identify the most cited Authors; 
• To identify the highly Cited papers; 
• To find research output on Covid-19 Drugs, Vaccines and Medicine; 
• To find Field-Weighted Citation Impact of Highly Cited Papers; 
 
MATERIALS AND METHODS 
 The Scopus tool, which restitutes for each article the number of citations, was used to 
search for the most cited articles of Covid-19 Drugs, Vaccines and Medicines interest. The 
search was conducted by introducing in the field “Covid-19 Drugs” or Covid-19 Vaccines” and 
Covid-19 Medicines, general terms that could capture all relevant articles. The top most cited 
100 articles were identified. A preliminary analysis of number of citations allowed us to set a 
cut-off of 100, 500 and 1000 Citations, so all articles that received a higher number of citations 
were extracted and listed to generate a rank based on absolute number of citations received by 
each article.  Concerning the country origin of the articles, individual countries have been listed 
if the authors derived from countries.  
 Field-Weighted Citation Impact shows how well cited this document is when compared 
to similar documents. A value greater than 1.00 means the document is more cited than expected 
according to the average. It takes into account: (i) The year of publication (ii) Document type, 
(iii) Disciplines associated with its source. The FWCI is the ratio of the document’s citations to 
the average number of citations received by all similar documents over a three-year window. 
Each discipline makes an equal contribution to the metric, which eliminates differences in 






DATA ANALYSIS AND INTERPRETATIONS 
 
Covid-19 Drugs: Citation Classic Papers  
 
 Among the Highly cited articles there were 22 articles received more than 1000 Citations, 
83 articles  received more than 500 Citations and 816 articles received 100 Citations. A total of 
22005 scientific journals had published the top 816 most cited articles in Covid-19 Drugs, 
Medicine and Vaccines of publications are published in reputed journals like The Lancet, Cell, 
Cell Research, New England Journal of Medicine, International Journal of Antimicrobial Agents, 
The Lancet Infectious Diseases, Allergy: Eropeans Journal of Allergy and Clinical Immunology, 
Military Medical Research, BioScience Trends, Journal of Hospital Infection, The Lancel 
Respiratory Medicine etc.. The most cited articles are: Zhou, F.a,  et al. (2020), Clinical course 
and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a 
retrospective cohort study(Article)(Open Access), The Lancet, Volume 395, Issue 10229, 28 
March - 3 April 2020, Pages 1054-1062  with 6860 Citations from China, followed by 
Hoffmann, M (2020), SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is 
Blocked by a Clinically Proven Protease Inhibitor(Article)(Open Access), Cell, Volume 181, 
Issue 2, 16 April 2020, Pages 271-280.e8 with 3845 Citations from Germany and Li, W.a et 
al.(2003), Angiotensin-converting enzyme 2 is a functional receptor for the SARS corona 
virus(Article)(Open Access), Nature, Volume 426, Issue 6965, 27 November 2003, Pages 450-
454 with 2425 Citations from USA.  
 
Classic papers (Highly Cited Papers) 
 
 
 Documents Citations <2017 2017 2018 2019 2020 2021 Sub 
total 
Total 
  Total 8864 483 437 501 43737 10428 55586 64450 
1 Clinical course and 
risk factors for 
mortality of adult 
inpa... 
2020    2 5488 1370 6860 6860 
2 SARS-CoV-2 Cell 
Entry Depends on 
ACE2 and 
TMPRSS2 and Is 






2 is a functional 
receptor for... 
2003 962 38 30 22 1139 234 1463 2425 
4 Remdesivir and 
chloroquine 
effectively inhibit 
the recently ... 
2020    3 1894 402 2299 2299 
5 First case of 2019 
novel coronavirus 
in the United States 
2020    1 1821 309 2131 2131 
6 Knocking down 
barriers: Advances 
in siRNA delivery 
2009 1381 193 172 175 125 43 708 2089 
7 Hydroxychloroquin
e and azithromycin 
as a treatment of 
COVID-... 
2020    1 1680 327 2008 2008 
8 Cryo-EM structure 
of the 2019-nCoV 
spike in the 
prefusion co... 
2020     1498 394 1892 1892 
9 A trial of lopinavir-
ritonavir in adults 
hospitalized with 
s... 
2020    1 1566 319 1886 1886 
10 Tissue distribution 
of ACE2 protein, 
the functional 
receptor... 
2004 242 11 7 4 1191 310 1523 1765 
11 Characterization of 
a novel coronavirus 
associated with 
seve... 
2003 1512 26 22 16 146 29 239 1751 
12 Structure, 
Function, and 
Antigenicity of the 
SARS-CoV-2 
Spik... 
2020    1 1288 399 1688 1688 
13 The genome 
sequence of the 
SARS-associated 
coronavirus 
2003 1319 14 15 16 109 25 179 1498 
14 A crucial role of 
angiotensin 




2 (ACE2) in ... 





2020     1081 270 1351 1351 
16 Angiotensin-
converting enzyme 
2 protects from 
severe acute l... 






2020    2 952 182 1136 1136 










2020     935 135 1070 1070 




2020    1 872 175 1048 1048 




2020    1 703 328 1032 1032 




2020     821 182 1003 1003 
23 Are patients with 
hypertension and 
diabetes mellitus at 
incr... 
2020    2 855 137 994 994 
24 Immune Signaling 
by RIG-I-like 
Receptors 
2011 498 93 101 118 125 31 468 966 
25 Compassionate use 
of remdesivir for 
2020     783 180 963 963 
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patients with severe 
Cov... 
26 Temporal profiles 
of viral load in 
posterior 
oropharyngeal s... 
2020    2 723 233 958 958 
27 Remdesivir in 
adults with severe 
COVID-19: a 
randomised, dou... 
2020     683 226 909 909 





1999 796 15 12 15 13 3 58 854 
29 Clinical evidence 
does not support 
corticosteroid 
treatment ... 
2020    1 746 101 848 848 
30 Genomic 
characterization of 
the 2019 novel 
human-pathogenic 
... 






2020    1 657 160 818 818 




2017  5 6 7 651 140 809 809 
33 Chloroquine is a 
potent inhibitor of 
SARS coronavirus 
infect... 
2005 66 4 2 4 609 109 728 794 
34 Role of 
lopinavir/ritonavir 
in the treatment of 
SARS: Initia... 
2004 134 4 4 10 549 89 656 790 
35 Coronavirus main 
proteinase 
(3CL<sup>pro</su
p>) Structure: B... 
2003 499 12 6 3 216 54 291 790 






37 Structural biology: 
Structure of SARS 
coronavirus spike 
rece... 





2020    1 651 110 762 762 




2020     609 150 759 759 
40 Epidemiologic 
Features and 
Clinical Course of 
Patients Infec... 
2020     617 132 749 749 





2020     521 225 746 746 
42 Hydroxychloroquin
e, a less toxic 
derivative of 
chloroquine, ... 
2020    1 606 121 728 728 
43 A rapid advice 
guideline for the 
diagnosis and 
treatment of ... 
2020    1 610 98 709 709 
44 Angiotensin-
converting enzyme 
2 (ACE2) as a 
SARS-CoV-2 
recep... 
2020     577 126 703 703 
45 Structural 
bioinformatics and 
its impact to 
biomedical scien... 
2004 586 26 13 36 18 5 98 684 




2020     509 165 674 674 








of remdesivir and 
combinati... 
2020    1 562 96 659 659 





2020     550 107 657 657 
50 The socio-
economic 
implications of the 
coronavirus 
pandemic ... 






PlumX is a web-primarily based totallydevicethat offersfactsat the use and effect of studies and 
scholarly products. It belongs to the small howeveran increasing number of influential network 
of alt-metric facts providers. ... Altmetrics additionallyconsist of a extensivetype of scholarly 

























Covid-19 Vaccines: Citation Classics  
 In Table 2, all terms used for searching the Scopus database are listed. A total of 6038 
articles were identified that produced Scopus search. Top most cited 105 articles collected with 
the range of 100 to 831 citations. The most cited papers indexed in high impact journals: The 
Lancet, Nature Communication, Journal of Advanced Research, Cell Asian Pacific Journal of 
Allergy and Immunology, JAMA Cardiology, Nature Reviews Drugs Discovery, Emerging 
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Microbes and Infections, Journal of Medical Virology, Journal of Pharmaceutical Analysis, 
BioScience Trends etc., and covers all the classical papers.  It is noted that 18 papers received 
more than 500 Citations, 202 papers have registered more than 100 Citations and only 3 papers 
received more than 1000 Citations. The most cited articles are: Wrapp, D.a,  et al. (2020), Cryo-
EM structure of the 2019-nCoV spike in the prefusion conformation(Article), Science,  Volume 
367, Issue 6483, 13 March 2020, Pages 1260-1263 with 1892 Citation(Field Weighted Citation 
Impact is 743.12 using PlumX Metrics) from United States followed by Walls, A.C.a et al., 
(2020), Structure, Function, and Antigenicity of the SARS-CoV-2 Spike 
Glycoprotein(Article)(Open Access), Cell, Volume 181, Issue 2, 16 April 2020, Pages 281-
292.e6 with 1988 Citations from USA and France (Field Weighted Citation Impact is 663.72  
using metrics) and Marra, M. A. (2003), The genome sequence of the SARS-associated 
coronavirus(Article)(Open Access), Science, Volume 300, Issue 5624, 30 May 2003, Pages 
1399-1404 with 1498 Citations from Canada (Field Weighted Citation Impact is 30.19  using 
metrics).  
 









2020 2021 Sub 
total 
Total 
Total 3099 291 284 292 8850 2469 12186 15285 
1 Cryo-EM structure of the 
2019-nCoV spike in the 
prefusion co... 
2020     1498 394 1892 1892 
2 Structure, Function, and 
Antigenicity of the SARS-
CoV-2 Spik... 
2020    1 1288 399 1688 1688 
3 The genome sequence of 
the SARS-associated 
coronavirus 
2003 1319 14 15 16 109 25 179 1498 
4 How will country-based 
mitigation measures 
influence the cou... 
2020    1 659 166 826 826 
5 Structural biology: 
Structure of SARS 
coronavirus spike rece... 
2005 257 10 15 15 392 78 510 767 
6 Angiotensin-converting 
enzyme 2 (ACE2) as a 
SARS-CoV-2 recep... 
2020     577 126 703 703 
7 Characterization of spike 
glycoprotein of SARS-
2020    1 501 165 667 667 
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CoV-2 on viru... 
8 COVID-19 infection: 
Origin, transmission, and 
characteristic... 
2020     470 156 626 626 
9 A SARS-CoV-2 protein 
interaction map reveals 
targets for dru... 
2020     430 183 613 613 




2020     417 175 592 592 
11 Broad-spectrum antiviral 
GS-5734 inhibits both 
epidemic and ... 




2015 113 114 107 100 127 19 467 580 
13 Severe acute respiratory 
syndrome 
2004 338 26 10 9 166 27 238 576 
14 Viral pneumonia 2011 306 61 51 59 90 7 268 574 
15 Targets of T Cell 
Responses to SARS-CoV-
2 Coronavirus in Hum... 
2020     389 177 566 566 
16 The spike protein of 
SARS-CoV - A target for 
vaccine and the... 
2009 93 15 8 11 348 79 461 554 
17 Immune responses in 
COVID-19 and potential 
vaccines: Lessons... 
2020     424 83 507 507 
18 Coronavirus avian 
infectious bronchitis virus 
2007 242 32 48 54 102 22 258 500 
 






















Covid-19 Medicine: Citation Classics 
 
 In Table 3, Covid-19 Medicines terms used for searching the Scopus database are listed. 
A total of 9533 articles were identified. Top most cited 26 articles with more than 400 Citations. 
It is noted that 5 papers with more than 1000 Citations followed by 15 papers with more than 500 
Citations and 141 papers with more than 100 Citations. The most Cited Classic Papers are: Chan, 
J.F.-W. et al., (2019), A familial cluster of pneumonia associated with the 2019 novel 
coronavirus indicating person-to-person transmission: a study of a family cluster(Article)(Open 
Access), The Lancet, Volume 395, Issue 10223, 15 - 21 February 2020, Pages 514-523 with 
2909 Citations from China (Field Weighted Citation Impact is 1215.43) followed by Rota, P.A. 
et al., (2003) Characterization of a novel coronavirus associated with severe acute respiratory 
syndrome(Article)(Open Access), Science, Volume 300, Issue 5624, 30 May 2003, Pages 1394-
1399 with 1751 Citations from USA, Netherland and Germany (Field Weighted Citation Impact 
is 33.74) and Shi, H.a,b et al.,  (2020), Radiological findings from 81 patients with COVID-19 
pneumonia in Wuhan, China: a descriptive study(Article)(Open Access), The Lancet Infectious 
Diseases, Volume 20, Issue 4, April 2020, Pages 425-434 with 1184 Citations from China (Field 
Weighted Citation Impact is 355. 33).  
 




Documents Citations <2017 2017 2018 201
9 
2020 2021 Sub 
total 
Total 
                                                    Total 2958 258 260 269 19746 4666 25199 28157 
1 A familial cluster of 
pneumonia associated 
with the 2019 nov... 
2020    5 2491 413 2909 2909 
2 Characterization of a 
novel coronavirus 
associated with seve... 
2003 1512 26 22 16 146 29 239 1751 
3 Radiological findings 
from 81 patients with 
COVID-19 pneumon... 
2020    1 984 199 1184 1184 
4 Angiotensin-converting 
enzyme 2 protects from 
severe acute l... 
2005 366 18 24 19 619 110 790 1156 




has shown apparent 
effic... 
6 Are patients with 
hypertension and 
diabetes mellitus at 
incr... 
2020    2 855 137 994 994 
7 Temporal profiles of 
viral load in posterior 
oropharyngeal s... 
2020    2 723 233 958 958 









2020     690 144 834 834 









2020    1 657 160 818 818 




2020     521 225 746 746 
13 A rapid advice 
guideline for the 
diagnosis and treatment 
of ... 
2020    1 610 98 709 709 
14 Database resources of 
the National Center for 
Biotechnology ... 
2016 34 134 159 156 127 33 609 643 
15 A Review of 
Coronavirus Disease-
2019 (COVID-19) 
2020     494 141 635 635 
16 Surviving Sepsis 
Campaign: guidelines 
on the management of 
c... 
2020     436 96 532 532 
17 A DNA vaccine 
induces SARS 




neutralization and pr... 
18 Coronavirus Disease 
2019 (COVID-19): 
Emerging and Future 
Cha... 
2020     359 80 439 439 
19 Unique epidemiological 
and clinical features of 
the emerging... 
2020     351 81 432 432 
20 Triple combination of 
interferon beta-1b, 
lopinavir–ritonavi... 
2020     320 106 426 426 
21 COVID-19 infection: 
the perspectives on 
immune responses 
2020    2 336 88 426 426 
22 Factors associated with 
COVID-19-related 
death using OpenSAF... 
2020     203 216 419 419 
23 Molecular Evolution of 
the SARS Coronavirus, 
during the Cour... 
2004 293 8 15 4 80 17 124 417 
24 Clinical and 
epidemiological 
features of 36 children 
with co... 
2020     344 67 411 411 
25 Potential interventions 
for novel coronavirus in 
China: A sy... 
2020    1 332 71 404 404 
26 Drug treatment options 
for the 2019-new 
coronavirus (2019-nC... 
2020    3 355 46 404 404 




2020     311 61 372 372 
28 Network-based drug 
repurposing for novel 
coronavirus 2019-nC... 
2020     298 70 368 368 
29 COVID-19: 
immunopathology and 
its implications for 
therapy 
2020     272 92 364 364 
30 Clinical features of 
COVID-19 in elderly 
patients: A compari... 
2020     277 85 362 362 
31 The Novel Coronavirus 2020     287 57 344 344 
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Originating in Wuhan, 
China: Challenge... 
32 Cardiovascular disease, 
drug therapy, and 
mortality in COVID... 
2020     269 69 338 338 
33 Clinical features and 
treatment of COVID-19 
patients in nort... 
2020     264 64 328 328 
34 Multisystem 
inflammatory syndrome 
in U.S. Children and 
adole... 
2020     206 120 326 326 
35 RETRACTED:Hydrox
ychloroquine or 
chloroquine with or 
without ... 
2020     255 61 316 316 
36 COVID-19: the 
gendered impacts of the 
outbreak 
2020     249 66 315 315 
37 Review of the Clinical 
Characteristics of 
Coronavirus Diseas... 
2020     258 56 314 314 
38 Airborne transmission 
of SARS-CoV-2: The 
world should face t... 
2020     208 105 313 313 
39 Coronavirus diversity, 
phylogeny and 
interspecies jumping 
2009 146 23 13 17 88 17 158 304 
40 Vaccines: Past, present 
and future 
2005 226 23 15 14 16 1 69 295 
41 Prevalence of 
depression, anxiety, 
and insomnia among 
health... 
2020     177 115 292 292 
42 Consensus guidelines 
for managing the 
airway in patients wit... 
2020     235 56 291 291 
43 Understanding of 
COVID-19 based on 
current evidence 
2020     236 40 276 276 




2020     224 48 272 272 
45 Diagnosis, treatment, 
and prevention of 2019 








2020     215 46 261 261 
47 Clinical features and 
obstetric and neonatal 
outcomes of pre... 
2020     218 42 260 260 
48 Clinical aspects and 
outcomes of 70 patients 
with Middle Eas... 
2014 58 19 10 19 130 23 201 259 




2020     167 75 242 242 
50 Prevalence of 
Underlying Diseases in 
Hospitalized Patients 
w... 
2020     179 56 235 235 
 




























FINDINGS AND CONCLUSION 
• The study found (Covid-19 Drugs, Vaccines and Medicines) that 22 articles received 
more than 1000 Citations, 83 articles have registered more than 500 Citations and 816 
articles recorded 100 Citations.  
• The study found most cited sources (Covid-19 Drugs, Vaccines and Medicines) are;  The 
Lancet, Cell, Cell Research, New England Journal of Medicine, International Journal of 
Antimicrobial Agents, The Lancet Infectious Diseases, Allergy: Eropeans Journal of 
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Allergy and Clinical Immunology, Military Medical Research, BioScience Trends, 
Journal of Hospital Infection, The Lancel Respiratory Medicine etc..  
• The study found (Covid-19 Drugs) that 12 articles received more than 1000 Citations, 46 
articles have registered more than 500 Citations and 338 articles recorded 100 Citations.  
• The most cited articles (Covid-19 Drugs) are: Zhou, F.a,  et al. (2020), Clinical course 
and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a 
retrospective cohort study(Article)(Open Access), The Lancet, with 6860 Citations from 
China.  
• The study found than top most cited 105 articles have received citations in the range  of 
100-831 .  
• It is noted that 18 papers received more than 500 Citations, 202 papers have  registered 
more than 100 Citations and only 3 papers received more than 1000 Citations.  
• The most cited (Covid-19 Vaccines) articles are: Wrapp, D.a,  et al. (2020), Cryo-EM 
structure of the 2019-nCoV spike in the prefusion conformation(Article), Science,  with 
1892 Citation(Field Weighted Citation Impact is 743.12 using PlumX Metrics) from 
United States  
• The study found the top most cited 26 articles with more than 400 Citations.  
• It is noted that 5 papers with more than 1000 Citations followed by 15 papers with more 
than 500 Citations and 141 papers with more than 100 Citations.  
• The most Cited Classic Papers (Covid-19 Medicines) are: Chan, J.F.-W. et al., (2019), A 
familial cluster of pneumonia associated with the 2019 novel coronavirus indicating 
person-to-person transmission: a study of a family cluster(Article)(Open Access), The 
Lancet, Volume 395, Issue 10223, 15 - 21 February 2020, Pages 514-523 with 2909 
Citations from China (Field Weighted Citation Impact is 1215.43)  
 
 In this study, we have evaluated the top 424 articles that had a high impact on the practice 
of Covid-19 Drugs, Vaccines and Mediciens, by assessing the number of times these articles 
were cited(100, 500 and 1000 Citations). The relevant Covid-19 Drugs, Vaccines and Medicines 
literature comes from English-based journals. Information from this analysis may help guide the 
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